• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Farmak works in the development, production and marketing of APIs, Intermediates & Specialties// FDA inspected.

    Captor Therapeutics Publishes Q1 2023 Financial Results

    GLOBENEWSWIRE

    Captor Discloses Molecular Targets of Pipeline Lead Assets

    GLOBENEWSWIRE

    Captor Therapeutics Announces Three-Year Strategic Objectives

    GLOBENEWSWIRE

    Captor Therapeutics Reports Q3 2022 Results and Provides Business Update

    GLOBENEWSWIRE

    Ono Pharma & Captor Therapeutics Announce Drug Discovery Collaboration

    GLOBENEWSWIRE

    Captor Therapeutics announces participation in upcoming scientific, investor, and partnering conferences in October 2022

    PRESS RELEASE

    Captor Therapeutics` first half of 2022 marked by significant progress in R&D and preparations for the commencement of clinical trials

    PRESS RELEASE

    Captor nominates the molecular glue CPT-6281 as drug candidate

    PHARMABIZ

    Captor Therapeutics Nominates the Molecular Glue CPT-6281 as Drug Candidate

    GLOBENEWSWIRE

    Captor Therapeutics Selects CDMO for Clinical Trial Materials

    CONTRACT PHARMA

    Captor Therapeutics to Host R&D Day on May 18, 2022

    GLOBENEWSWIRE

    Captor Therapeutics announces molecular targets of CT-01 program

    GLOBENEWSWIRE

    Captor Therapeutics Invited to TPD Panel at 8th Annual LSX World Congress 2022

    GLOBENEWSWIRE

    Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.